Plasma Cyclooxygenase-2 as a Potential Biomarker for Early Diagnosis of Kawasaki Disease

References

• McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99. doi:10.1161/CIR.0000000000000484.
   PubMed Web of Science ®Google Scholar
• Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Kawasaki disease. Arthritis Rheumatol. 2022;74(4):586–96. doi:10.1002/art.42041.
   PubMed Web of Science ®Google Scholar
• Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, Cardinale F, Cattalini M, De Zorzi A, Dellepiane RM, et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021;47(1):16. doi:10.1186/s13052-021-00962-4.
   PubMed Web of Science ®Google Scholar
• Ozen G, Norel X. Prostanoids in the pathophysiology of human coronary artery. Prostaglandins Other Lipid Mediat. 2017;133:20–8. doi:10.1016/j.prostaglandins.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Li S, Shi R, Tian L, Chen J, Li X, Huang L, Yang Z. The relationship of COX-2 gene polymorphisms and susceptibility to Kawasaki disease in Chinese population. Immunol Invest. 2019;48(2):181–9. doi:10.1080/08820139.2018.1529790.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T, Kamada M, Shiono J, Suda K, Tsuchiya K, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr Int. 2020;62(10):1135–8. doi:10.1111/ped.14326.
   PubMed Web of Science ®Google Scholar
• Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol. 2010;31(2):242–9. doi:10.1007/s00246-009-9599-7.
   PubMed Web of Science ®Google Scholar
• Galeotti C, Kaveri SV, Cimaz R, Koné-Paut I, Bayry J. Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease. Drug Discov Today. 2016;21(11):1850–7. doi:10.1016/j.drudis.2016.08.004.
   PubMed Web of Science ®Google Scholar
• Greco A, De Virgilio A, Rizzo MI, Tombolini M, Gallo A, Fusconi M, Ruoppolo G, Pagliuca G, Martellucci S, de Vincentiis M. Kawasaki disease: An evolving paradigm. Autoimmun Rev. 2015;14(8):703–9. doi:10.1016/j.autrev.2015.04.002.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum. 2013;65(3):805–14. doi:10.1002/art.37815.
   PubMed Web of Science ®Google Scholar
• Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 2010;162(1):131–7. doi:10.1111/j.1365-2249.2010.04236.x.
   PubMed Web of Science ®Google Scholar
• Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarévian JP, Perlman EJ, et al. Three linked vasculopathic processes characterize Kawasaki disease: A light and transmission electron microscopic study. PLoS One. 2012;7(6):e38998. doi:10.1371/journal.pone.0038998.
   PubMed Web of Science ®Google Scholar
• Kawabe J, Ushikubi F, Hasebe N. Prostacyclin in vascular diseases. - Recent insights and future perspectives. Circ J. 2010;74(5):836–43. doi:10.1253/circj.cj-10-0195.
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Kirkby NS. Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. Br J Pharmacol. 2019;176(8):1038–50. doi:10.1111/bph.14167.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol. 2005;25(9):1925–31. doi:10.1161/01.ATV.0000177814.41505.41.
   PubMed Web of Science ®Google Scholar
• Yang G, Chen L. An update of microsomal prostaglandin E synthase-1 and PGE2 receptors in cardiovascular health and diseases. Oxid Med Cell Longev. 2016;2016:5249086. doi:10.1155/2016/5249086.
   PubMed Web of Science ®Google Scholar
• Yao C, Hirata T, Soontrapa K, Ma X, Takemori H, Narumiya S. Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase. Nat Commun. 2013;4:1685. doi:10.1038/ncomms2684.
   PubMed Web of Science ®Google Scholar
• Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015;1851(4):414–21. doi:10.1016/j.bbalip.2014.07.008.
   PubMed Web of Science ®Google Scholar
• Kuo HC, Wang CL, Yang KD, Lo MH, Hsieh KS, Li SC, Huang YH. Plasma prostaglandin E2 levels correlated with the prevention of intravenous immunoglobulin resistance and coronary artery lesions formation via CD40L in Kawasaki disease. PLoS One. 2016;11(8):e0161265. doi:10.1371/journal.pone.0161265.
   PubMed Web of Science ®Google Scholar
• Yahata T, Hamaoka K. Oxidative stress and Kawasaki disease: How is oxidative stress involved from the acute stage to the chronic stage? Rheumatology (Oxford)). 2017;56(1):6–13. doi:10.1093/rheumatology/kew044.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Seki K. The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease. BMC Cardiovasc Disord. 2018;18(1):30. doi:10.1186/s12872-018-0765-9.
   PubMedGoogle Scholar
• Pérez-Cremades D, Bueno-Betí C, García-Giménez JL, Ibañez-Cabellos JS, Hermenegildo C, Pallardó FV, Novella S. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells. J Cell Mol Med. 2017;21(8):1584–92. doi:10.1111/jcmm.13088.
   PubMed Web of Science ®Google Scholar
• Peng Y, Pei Q, Feng S, Su Y, Liu R, Yi Q, Guo P. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease. Clin Exp Med. 2019;19(4):457–62. doi:10.1007/s10238-019-00577-4.
   PubMed Web of Science ®Google Scholar
• Li G, Wang T, Li J, Chen P, Jia P, Zhao J, Duan Y, Liu D, Xu X, Liu B. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease. Clin Chim Acta. 2020;507:264–70. doi:10.1016/j.cca.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Singh A, Rawat A, Kaur A, Kaur A, Kumrah R, Johnson N, Chaudhary H, Pilania RK, Srivastava P, Singh S. Association of SNP (rs1042579) in thrombomodulin gene and plasma thrombomodulin level in North Indian children with Kawasaki disease. Mol Biol Rep. 2022;49(8):7399–407. doi:10.1007/s11033-022-07533-8.
   PubMed Web of Science ®Google Scholar
• Liao Y, Ke B, Long X, Xu J, Wu Y. Upregulated expression of IL2RB causes disorder of immune microenvironment in patients with Kawasaki disease. Biomed Res Int. 2022;2022:2114699. doi:10.1155/2022/2114699.
   PubMed Web of Science ®Google Scholar
• Garami A, Steiner AA, Romanovsky AA. Fever and hypothermia in systemic inflammation. Handb Clin Neurol. 2018;157:565–97. doi:10.1016/B978-0-444-64074-1.00034-3.
   PubMedGoogle Scholar